INTRODUCTION
Chronic Obstructive Pulmonary Disease (COPD) is a chronic respiratory disease that is equally present in developed and developing countries. Previously emphasis was focused on smoking. But with more available diagnostic facilities, COPD is being diagnosed more accurately and hence prevalence is increasing. It has become a significant health problem throughout the world. The epidemiological, clinical and socio-economical impact of comorbidities of COPD has been studied by many 1, 2 . Importance of comorbidities in COPD increases due to the fact that COPD is projected to be 3 rd leading cause of death in the world by 2030 and 7 th as a burden of disease 3, 4 . COPD can progressively affect functions of multiple organs thus several comorbidities prevail in elderly patients. As a result management complexity, costing and hospital stay increasing significantly than that of COPD without comorbidities.
The objective of present study is to detect comorbidities, costing and average hospital stay at Private Hospital setting of Chattogram.
MATERIALS AND METHODS
It was a descriptive study conducted in 2017 at 4 major Private Hospitals (Over 100 bedded ) of Chattogram. Properly diagnosed (History, clinical features, spirometry and others) all COPD case records were studied. Asthma, Emphysema with bulla and oncogenic cases were excluded. Sample size was 1490 and it was determined purposively considering resources. Trained data collectors collected data with a pretested checklist. Professional data manager managed data. SPSS version 20 was used. 
DISCUSSION
COPD is a major cause of morbidity and mortality across the globe. It is increasing and its socio-economic impact is grave. Many studies were conducted on the subject worldwide to measure prevalence and pattern of comorbidities. Present findings conform with that studies 5, 6 . The highest comorbidity is diabetes mellitus and it is quite logical because it is ever increasing in this region. It complicates Hypertension, Ischaemic heart disease etc. Frequency of hospitalization, average duration of hospital stay and costing all are significantly more in COPD cases with comorbidities (p=.03, CI=95%). We found that during COPD exacerbation management of comorbidities become difficult even with aggressive therapy. This is particularly true in cardiac and diabetic patients. This could be due to over cautious effort not to destabilize either COPD symptoms or comorbidity symptoms. This leads to longer stay in hospital in comorbidity group.
CONCLUSION
Prevalence and pattern of comorbidities have been focused. Every physician must know about it and should be equipped well to manage COPD and its comorbidities.
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